1.Obesity and Gallbladder Diseases.
The Korean Journal of Gastroenterology 2012;59(1):27-34
Obesity is an important health problem in the world and related to many critical diseases, such as diabetes, cardiovascular disease, and metabolic syndrome. Obesity leads to fat infiltration of multiple organs and infiltrated adipose tissue produces many cytokines resulting in the dysfunction of organs such as the gallbladder. In the biliary diseases, obesity and overweight have been known as a major risk factor for gallstones. According to current studies, obesity, insulin resistance, hyperinsulinemia, and metabolic syndrome are related to various gallbladder diseases including gallbladder stones, cholecystitis, gallbladder polyps, and gallbladder cancers. We reviewed further literature on the obesity and gallbladder diseases, in aspects of epidemiology, mechanism, pathology and prevention.
Body Mass Index
;
Cholecystitis/etiology
;
Exercise
;
Gallbladder Diseases/drug therapy/epidemiology/*etiology/prevention & control
;
Gallbladder Neoplasms/epidemiology/etiology
;
Gallstones/epidemiology/etiology
;
Humans
;
Hyperinsulinism
;
Hypolipidemic Agents/therapeutic use
;
Insulin Resistance
;
Obesity/*complications
;
Ursodeoxycholic Acid/therapeutic use
;
Weight Loss
2.Shifting Prevalence of Gallbladder Polyps in Korea.
Yoo Jin LEE ; Kyung Sik PARK ; Kwang Bum CHO ; Eun Soo KIM ; Byoung Kuk JANG ; Woo Jin CHUNG ; Jae Seok HWANG
Journal of Korean Medical Science 2014;29(9):1247-1252
Only a few studies have evaluated the population-adjusted prevalence of gallbladder polyps (GBP). This study aimed to evaluate the changes in GBP prevalence and risk factors at a single health screening center in Korea from 2002 to 2012. Of 48,591 adults who underwent health screening between 2002 and 2012, 14,250 age- and gender-matched subjects were randomly selected to evaluate prevalence. Risk factors were analyzed between the GBP-positive and GBP-negative groups during 2002-2004 (Period A) and 2010-2012 (Period B). The annual prevalence of GBP over the 11-yr period was 5.4%. Annual prevalence increased from 3.8% in Period A to 7.1% in Period B. Male gender and obesity were independent risk factors for GBP in both periods. Hepatitis B virus surface antigen (HBsAg) positivity was a risk factor for GBP in Period A but not in Period B. The risk factors for GBP changed from HBsAg positivity to lipid profile abnormalities. Other variables including age, hypertension, diabetes, impaired fasting glucose, chronic hepatitis C virus infection, and liver function tests did not correlate with GBP. In conclusion, GBP prevalence is increasing and risk factors for GBP have changed in Korea. More attention should be paid to this issue in the future.
Adult
;
Aged
;
Female
;
Gallbladder Diseases/complications/*epidemiology
;
Hepatitis B/complications
;
Hepatitis B Surface Antigens/blood
;
Humans
;
Male
;
Middle Aged
;
Obesity/complications
;
Polyps/*epidemiology/pathology
;
Prevalence
;
Republic of Korea/epidemiology
;
Risk Factors
;
Sex Factors
3.Changes in Sonographic Findings after Treatment of Patients with Clonorchiasis in a Heavy Endemic Area.
Dongil CHOI ; Yong Hwan JEON ; Geun Chan LEE ; Min Ho CHOI ; Sung Tae HONG
The Korean Journal of Parasitology 2009;47(1):19-23
We measured changes in sonographic findings of patients with clonorchiasis after a treatment in a highly endemic area. A total of 347 residents showed positive stool results for Clonorchis sinensis eggs in a village in northeastern China, and were treated with praziquantel. Of them, 132 patients underwent abdominal sonography both before and 1 year after treatment, and the changes in sonographic findings of 83 cured subjects were compared. Diffuse dilatation of intrahepatic bile ducts (DDIHD) was found in 82 patients (98.2%) before and 80 (96.4%) after treatment, which was improved in 3, aggravated in 1, and unchanged in 79 patients. Increased periductal echogenicity (IPDE) was observed in 42 patients (50.6%) before and 45 (54.2%) after treatment, which was improved in 5, aggravated in 8, and unchanged in 70 patients. Floating echogenic foci in the gallbladder (FEFGB) was detected in 32 patients (38.6%) before and 17 (20.5%) after treatment, which was improved in 20, aggravated in 5, and unchanged in 58 patients. Improvement of FEFGB only was statistically significantly (P = 0.004). The present results confirm that DDIHD and IPDE persist but FEFGB decreases significantly at 1 year after treatment. In a heavy endemic area, the sonographic finding of FEFGB may suggest active clonorchiasis 1 year after treatment.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Bile Ducts, Intrahepatic/parasitology/ultrasonography
;
Child
;
China/epidemiology
;
Clonorchiasis/complications/*drug therapy/epidemiology/*ultrasonography
;
*Endemic Diseases
;
Female
;
Gallbladder/parasitology/ultrasonography
;
Humans
;
Male
;
Middle Aged
;
Praziquantel/*therapeutic use
;
Treatment Outcome
;
Young Adult
4.Visceral Obesity If Associated with Gallbladder Polyps.
Jun Kyu LEE ; Suk Jae HAHN ; Hyoun Woo KANG ; Jae Gu JUNG ; Han Seok CHOI ; Jin Ho LEE ; In Woong HAN ; Jin Hee JUNG ; Jae Hyun KWON
Gut and Liver 2016;10(1):133-139
BACKGROUND/AIMS: Gallbladder polyps (GBP) are a common clinical finding and may possess malignant potential. We conducted this study to determine whether visceral obesity is a risk factor for GBP. METHODS: We retrospectively reviewed records of subjects who received both ultrasonography and computed tomography with measurements of the areas of visceral adipose tissue and total adipose tissue (TAT) on the same day as health checkups. RESULTS: Ninety-three of 1,615 subjects (5.8%) had GBP and were compared with 186 age- and sex-matched controls. VAT (odds ratio [OR], 2.941; 95% confidence interval [CI], 1.325 to 6.529; p=0.008 for the highest quartile vs the lowest quartile) and TAT (OR, 3.568; 95% CI, 1.625 to 7.833; p=0.002 for the highest quartile vs the lowest quartile) were independent risk factors together with hypertension (OR, 2.512; 95% CI, 1.381 to 4.569; p=0.003), diabetes mellitus (OR, 2.942; 95% CI, 1.061 to 8.158; p=0.038), hepatitis B virus positivity (OR, 3.548; 95% CI, 1.295 to 9.716; p=0.014), and a higher level of total cholesterol (OR, 2.232; 95% CI, 1.043 to 4.778; p=0.039 for <200 mg/dL vs > or =240 mg/dL). Body mass index and waist circumference were not meaningful variables. CONCLUSIONS: Visceral obesity measured by VAT and TAT was associated with GBP irrespective of body mass index or waist circumference.
Adipose Tissue/ultrasonography
;
Adult
;
Case-Control Studies
;
Cholesterol/blood
;
Diabetes Complications
;
Female
;
Gallbladder Diseases/blood/epidemiology/*etiology
;
Hepatitis B/complications
;
Humans
;
Hypertension/complications
;
Intra-Abdominal Fat/ultrasonography
;
Male
;
Middle Aged
;
Obesity, Abdominal/blood/*complications/ultrasonography
;
Odds Ratio
;
Polyps/blood/epidemiology/*etiology
;
Prevalence
;
Retrospective Studies
;
Risk Factors